NCT00462020View on ClinicalTrials.gov

Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Perforated Appendicitis
Interventions
DRUG

5 days of IV antibiotics (ceftriaxone and metronidazole)

5 days of IV antibiotics (ceftriaxone and metronidazole once a day dosing)

DRUG

Home with oral antibiotics when eating (ampicillin/clavulanic acid)

Augmentin 40mg/kg BID when tolerating POs to complete 7 days total

Trial Locations (1)

64108

Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT00462020 - Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis | Biotech Hunter | Biotech Hunter